Erica Rice

Partner - Boston

Bio photo for Erica Rice
Download Media Photo

Contact Information

Erica Rice is a partner in the firm’s Business Department. Erica’s practice is focused on representing buyers and sellers in mergers and acquisitions and other strategic transactions, as well as counseling early and mid-stage companies regarding entity formation, founder’s arrangements, financings, licensing agreements, exit strategies and general corporate governance.

More »

Education:

  • Boston University School of Law, J.D., cum laude, 2010
  • University of Michigan, B.A., with high distinction, 2004

Representative Experience

  • Represented Ascend Wellness Holdings, a multi-state, vertically integrated cannabis operator, in the acquisition of Greenleaf Compassion Center, a New Jersey vertically integrated cannabis company
  • Advised global cannabis operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in its pending acquisition of The Green Solution (“TGS”), the largest vertically integrated cannabis operator in Colorado, through a transaction initially valued at approximately $140 million  
  • Represented digital financial company BlockFi, Inc. in closing its $37M Series B financing 
  • Represents numerous early stage companies in seed stage and venture financing transactions, including BlockFi, Pear Therapeutics, InsightSquared, MiniLuxe, American Aerogel Corporation, Senti Biosciences and Glympse Bio
  • Represents numerous venture capital firms, including Accomplice, Cue Ball Capital, Safeguard Scientifics and Flagship Pioneering, in their portfolio investment activities
  • Represented LevelUp, a leader in mobile diner engagement and payment solutions for restaurants, in its $390M sale to online and mobile food-ordering and delivery marketplace Grubhub Inc.
  • Represented mobile-focused voting and citizen engagement platform Voatz in its $7 million Series A financing
  • Represented global cybersecurity leader RSA in its acquisition of Fortscale
  • Represented Orig3n in its acquisition of Interleukin Genetics
  • Represented L2, Inc. in its acquisition by Gartner, Inc.
  • Represented Thermo Fisher Scientific in its acquisition of MTI-GlobalStem
  • Represented CloudLock in its acquisition by Cisco
  • Represented Pegasystems in its acquisition of OpenSpan
  • Represented Resilient Systems in its acquisition by IBM
  • Represented Litmus in its $49 million investment from Spectrum Equity
  • Represented Viewfinity in its acquisition by CyberArk
  • Represented EMC Corporation in numerous mergers and acquisitions
  • Represented Applied Genetic Technologies Corporation in $52 million initial public offering and subsequent $30 million follow-on public offering

Honors

  • Ranked by Venture Capital Journal as one of Venture capital's 40 rising stars (2020) 
  • Ranked by Chambers USA: America's Leading Lawyers for Business as one of Massachusetts' leading Corporate/M&A attorneys (2016, 2017) 
  • Boston University Law Review, Administrative Editor

Involvement

  • Boston Bar Association, Member 
  • Women’s Bar Association, Member
  • Panelist “Alternative Entities Top Ten: Liability and Governance Issues for Deal Attorneys and Litigators” American Bar Association Business Law Section Annual Meeting 2019 (September 2019)
  • Moderator “Fireside Chat: Investing in Cannabis” The Cannabis Society Investor Conference (August 2019)
  • Panelist “Regulatory Considerations and Blockchain Technologies: Best Practices for In-House Counsel” Association of Corporate Counsel – Northeast – Webinar (May 2018)
  • Panelist “Understanding ICOs – The Latest in Crowdfunding, Currency and Cons” Boston Blockchain Week (April 2018)
  • Presenter “Incorporation for Startups – Why Delaware? Why a C-Corp?” Boston New Technology Showcase (December 2016) 
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts